AstraZeneca PLC (AZN)
204.20
-4.42
(-2.12%)
USD |
NYSE |
Feb 20, 16:00
204.29
+0.09
(+0.04%)
Pre-Market: 20:00
AstraZeneca Profit Margin (Quarterly) : 15.02% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| GSK Plc | 8.44% |
| Mereo BioPharma Group Plc | -- |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Biodexa Pharmaceuticals Plc | -- |
| Bicycle Therapeutics Plc | -503.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.12% |
| Return on Assets | 9.29% |
| Return on Invested Capital | 13.53% |
| Gross Profit Margin (Quarterly) | 72.19% |
| Operating Margin (Quarterly) | 18.93% |
| Return on Net Operating Assets | 11.18% |